Skip to main content

Table 1 Demographic and baseline characteristics of the overall cohort stratified by mean heart rate

From: Assessment of the impact of resting heart rate on the risk of major adverse cardiovascular events after ischemic stroke: a retrospective observational study

 

Mean heart rate

P value

Total (n = 21,655)

 < 60 bpm (n = 1,680)

60–69 bpm (n = 5,834)

70–79 bpm (n = 7,914)

80–89 bpm (n = 4,027)

 ≥ 90 (n = 2,200)

Age (years)

< .001

 Mean (SD)

67.35 (12.93)

67.84 (11.53)

66.73 (12.28)

66.72 (12.91)

67.88 (13.58)

69.96 (14.03)

 

 Median (Q1, Q3)

68 (59, 77)

68 (60, 76)

67 (59, 76)

67 (58, 77)

69 (59, 78)

72 (61, 81)

 

Men, n (%)

13,400 (61.88)

1,224 (72.86)

3,829 (65.63)

4,902 (61.94)

2,262 (56.17)

1,183 (53.77)

< .001

eNIHSS

< .001

 Mean (SD)

7.25 (5.88)

5.60 (4.00)

5.73 (4.11)

6.36 (4.87)

8.40 (6.48)

13.65 (8.16)

 

 Median (Q1, Q3)

4 (4, 8)

4 (4, 4)

4 (4, 4)

4 (4, 6)

4 (4, 11)

14 (4, 20)

 

Medical history, n (%)

 Hypertension

16,167 (74.66)

1,267 (75.42)

4,437 (76.05)

5,983 (75.60)

3,004 (74.60)

1,476 (67.09)

< .001

 Diabetes mellitus

8,680 (40.08)

468 (27.86)

2,013 (34.50)

3,362 (42.48)

1,879 (46.66)

958 (43.55)

< .001

 Dyslipidemia

9,764 (45.09)

846 (50.36)

2,845 (48.77)

3,682 (46.53)

1,692 (42.02)

699 (31.77)

< .001

 Atrial fibrillation

3,106 (14.34)

151 (8.99)

547 (9.38)

929 (11.74)

796 (19.77)

683 (31.05)

< .001

 Coronary artery disease

1,917 (8.85)

140 (8.33)

467 (8.00)

660 (8.34)

403 (10.01)

247 (11.23)

< .001

 Heart failure

1,179 (5.44)

59 (3.51)

219 (3.75)

387 (4.89)

274 (6.80)

240 (10.91)

< .001

Current smoker, n (%)

5,967 (27.55)

618 (36.79)

1,885 (32.31)

2,087 (26.37)

902 (22.40)

475 (21.59)

< .001

History of cancer, n (%)

1,452 (6.71)

103 (6.13)

307 (5.26)

494 (6.24)

299 (7.42)

249 (11.32)

< .001

Body mass index (kg/m2)

< .001

 Mean (SD)

24.84 (4.24)

24.79 (3.78)

24.97 (4.01)

25.02 (4.31)

24.73 (4.39)

24.21 (4.59)

 

 Median (Q1, Q3)

24.5 (22.1, 27.2)

24.6 (22.4, 27.1)

24.7 (22.4, 27.2)

24.7 (22.2, 27.4)

24.3 (21.9, 27.2)

23.8 (21.2, 26.7)

 

Laboratory data

 Total cholesterol (mmol/L)

< .001

  Mean (SD)

4.62 (1.13)

4.56 (1.01)

4.64 (1.03)

4.67 (1.11)

4.63 (1.26)

4.44 (1.26)

 

  Median (Q1, Q3)

4.53 (3.89, 5.23)

4.51 (3.89, 5.13)

4.56 (3.94, 5.23)

4.56 (3.91, 5.28)

4.51 (3.81, 5.26)

4.30 (3.63,5.13)

 

 Triglyceride (mmol/L)

< .001

  Mean (SD)

1.52 (1.13)

1.40 (0.88)

1.49 (0.92)

1.56 (1.17)

1.58 (1.29)

1.42 (1.31)

 

  Median (Q1, Q3)

1.25 (0.90, 1.79)

1.22 (0.89, 1.70)

1.27 (0.92, 1.77)

1.29 (0.93, 1.84)

1.25 (0.90, 1.86)

1.13 (0.80, 1.64)

 

 LDL cholesterol (mmol/L)

< .001

  Mean (SD)

2.86 (0.94)

2.87 (0.85)

2.90 (0.89)

2.88 (0.93)

2.84 (1.03)

2.71 (1.01)

 

  Median (Q1, Q3)

2.79 (2.22, 3.41)

2.81 (2.30, 3.36)

2.84 (2.30, 3.41)

2.82 (2.25, 3.44)

2.74 (2.17, 3.41)

2.59 (2.02, 3.28)

 

 eGFR (mL/min/1.73 m2)

< .001

  Mean (SD)

76.98 (32.57)

78.07 (26.73)

79.55 (29.17)

77.80 (32.29)

74.30 (35.54)

71.30 (38.85)

 

  Median (Q1, Q3)

76.96 (57.05, 96.26)

77.86 (61.25, 94.51)

79.47 (61.22, 97.35)

77.93 (58.23, 97.08)

73.91 (51.56, 95.51)

69.06 (46.35, 91.83)

 

 ALT (U/L)

< .001

  Mean (SD)

26.85 (33.43)

25.57 (22.70)

26.31 (23.73)

26.57 (26.09)

27.67 (55.32)

28.80 (32.50)

 

  Median (Q1, Q3)

21 (16, 29)

21 (16, 28)

21 (16, 29)

21 (16, 30)

20 (15, 29)

21 (15, 31)

 

 HbA1c (%)

< .001

  Mean (SD)

6.89 (1.89)

6.37 (1.28)

6.68 (1.71)

6.93 (1.89)

7.17 (2.10)

7.15 (2.16)

 

  Median (Q1, Q3)

6.1 (5.7, 7.4)

5.9 (5.6, 6.5)

6.0 (5.7, 7.0)

6.2 (5.7, 7.6)

6.3 (5.7, 8.0)

6.3 (5.7, 7.9)

 

 Mean SBP (mmHg)

< .001

  Mean (SD)

151.04 (19.64)

153.40 (20.27)

151.90 (19.52)

150.73 (19.13)

151.58 (20.01)

146.91 (19.98)

 

  Median (Q1, Q3)

153.1 (137.2, 164.5)

153.1 (139.4, 167.6)

153.9 (138.1, 165.3)

149.2 (137.1, 163.7)

151.1 (137.9, 165.4)

146.1 (133.0, 161.0)

 

 Mean DBP (mmHg)

< .001

  Mean (SD)

84.81 (11.17)

82.56 (10.97)

84.38 (10.94)

85.21 (10.69)

86.02 (11.67)

84.01 (12.28)

 

  Median (Q1, Q3)

84.3 (77.2, 92.1)

82.2 (75.2, 89.5)

83.9 (76.9, 91.5)

84.4 (78.0, 92.0)

85.5 (78.0, 94.2)

84.0 (75.9, 92.5)

 

 Medications at discharge, n (%)

  Antithrombotics

20,731 (95.73)

1,645 (97.92)

5,688 (97.50)

7,647 (96.62)

3,802 (94.41)

1,949 (88.59)

< .001

  Statins

11,380 (52.55)

942 (56.07)

3,232 (55.40)

4,179 (52.81)

2,045 (50.78)

982 (44.64)

< .001

  Beta-blockers

7,430 (34.31)

428 (25.48)

1,777 (30.46)

2,666 (33.69)

1,541 (38.27)

1,018 (46.27)

< .001

  1. Abbreviations: bpm beats per minute, n number, D standard deviation, Q quartile, eNIHSS estimated National Institute of Health Stroke Scale, LDL low density lipoprotein, eGFR estimated Glomerular filtration rate, ALT alanine aminotransferase, HbA1c glycated hemoglobin, SBP systolic blood pressure, DBP diastolic blood pressure